ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Docosahexaenoic Acid Derivative (N-Benzyl Docosahexaenamide) as a Potential Therapeutic Candidate for Treatment of Ovarian Injury in the Mouse Model

Guo, Lirong; Gao, Qing; Zhu, Jieqiong; Jin, Xiaobao; Yin, Hui*; Liu, Tao*广东药学院
MOLECULES2022-5DOI: 10.3390/molecules27092754
3被引3阅读
引用收藏
分享

摘要

Commonly used clinical chemotherapy drugs, such as cyclophosphamide (CTX), may cause injury to the ovaries. Hormone therapies can reduce the ovarian injury risk; however, they do not achieve the desired effect and have obvious side effects. Therefore, it is necessary to find a potential therapeutic candidate for ovarian injury after chemotherapy. N-Benzyl docosahexaenamide (NB-DHA) is a docosahexaenoic acid derivative. It was recently identified as the specific macamide with a high degree of unsaturation in maca (Lepidium meyenii). In this study, the purified NB-DHA was administered intragastrically to the mice with CTX-induced ovarian injury at three dose levels. Blood and tissue samples were collected to assess the regulation of NB-DHA on ovarian function. The results indicated that NB-DHA was effective in improving the disorder of estrous cycle, and the CTX+NB-H group can be recovered to normal levels. NB-DHA also significantly increased the number of primordial follicles, especially in the CTX+NB-M and CTX+NB-H groups. Follicle-stimulating hormone and luteinizing hormone levels in all treatment groups and estradiol levels in the CTX+NB-H group returned to normal. mRNA expression of ovarian development-related genes was positive regulated. The proportion of granulosa cell apoptosis decreased significantly, especially in the CTX+NB-H group. The expression of anti-Mullerian hormone and follicle-stimulating hormone receptor significantly increased in ovarian tissues after NB-DHA treatment. NB-DHA may be a promising agent for treating ovarian injury.

学科与关键词

关键词
docosahexaenoic acidsovarygranulosa cellscyclophosphamidemacamide
相关
加载中…
  • Hyperoside protects against cyclophosphamide induced ovarian damage and reduced fertility by suppressing HIF-1α/BNIP3-mediated autophagy
    Zhu, Fangfang; Gao, Jie; Zeng, Fuling; Lai, Yuling; Ruan, Xiaofeng; Deng, Gaopi*Biomedicine and Pharmacotherapy, 2022, 156: 113743.被引 5
  • Berberine protects cyclophosphamide and busulfan-induced premature ovarian insufficiency in mouse model
    Peng, Ying; Sun, Lu; Guo, Wentong; Liu, Zhigang; Wang, Tianxiang; Zou, Tingfeng; Zhou, Jie; Yang, Xiaoxiao*; Fan, Xiaodong*Journal of Pharmacological Sciences, 2023, 153(1): 46-54.
  • Preventive effect of swim bladder hydrolysates on cyclophosphamide-induced ovarian injury in mice
    Ge, Enhui; Zha, Rui; Gao, Qing; Guo, Lirong; Wang, Binglong; Lin, Qiqi; Zhang, Guifeng; Xie, Weiquan; Yin, Hui; Liu, Tao*JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48(2): 420-430.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
MOLECULES
发表日期
2022-05
卷期
第 27 卷, 第 9 期
页码
2754
DOI
10.3390/molecules27092754
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81770527, 82171700]; Shenzhen Longgang District medical and health science and technology plan project [LGKCYLWS2021000022]

作者

  • G

    Guo, Lirong (第一作者)

    guangdong pharmaceut univ

  • G

    Gao, Qing

    guangdong pharmaceut univ

查看全部 6 位作者收起作者
  • Z

    Zhu, Jieqiong

    guangdong pharmaceut univ

  • J

    Jin, Xiaobao

    guangdong pharmaceut univ

  • Y

    Yin, Hui (通讯)

    guangdong pharmaceut univ

  • L

    Liu, Tao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417